Income StatementBalance SheetCash FlowSegments
Neurocrine Biosciences logo

Neurocrine Biosciences Business Segments

Business, geographic, and product segment breakdowns

Neurocrine Biosciences generates $3.1B in annual revenue across 1 key segments: Business Segments ($56.7M). The company-wide operating margin is 25.43%. Based on the Q1 2026 filing.

Business Segments (TTM)$56.7M
Latest FilingQ1 2026
Report Date2026-05-05
Market Cap$15.7B
P/E Ratio23.52
ROE22.5%

Products & Services

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenues$6.5M$8.9M$5.5M$5.0M$7.2M$3.5M

Business Segments

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenues$627.7M$572.6M$687.5M$794.9M$805.5M$814.5M
Selling, general, and administrative$287.8M$276.5M$286.3M$291.6M$301.8M$318.5M
R&D$185.6M$263.2M$244.3M$250.0M$258.2M$296.2M
Net Income$103.1M$7.9M$107.5M$209.5M$153.7M$197.9M
Provision for income taxes$59.5M$6.8M$52.0M$82.3M$85.7M$48.9M
Investment income and other, net$22.5M$21.7M$20.6M$22.2M$25.8M$28.1M
Unrealized gain (loss) on equity investments-$1.9M-$30.6M-$6.7M$30.6M—$25.3M
Acquired in-process research and development$3.0M$100.0K$0.0$300.0K$17.0M$21.2M
Cost of revenues$9.3M$9.2M$11.3M$14.0M$17.6M$13.8M